Agenus, Inc. (AGEN)
7.42
-0.25
(-3.26%)
USD |
NASDAQ |
Oct 12, 16:00
7.42
0.00 (0.00%)
After-Hours: 20:00
Agenus Price : 7.42 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 7.495 | 7.793 | 7.38 | 7.67 | 710289.0 |
| Oct 08, 2026 | 7.565 | 7.66 | 7.24 | 7.54 | 1.215M |
| Oct 07, 2026 | 7.28 | 7.62 | 7.27 | 7.57 | 1.156M |
| Oct 06, 2026 | 8.49 | 8.49 | 7.47 | 7.49 | 1.527M |
| Oct 05, 2026 | 8.54 | 8.76 | 8.110 | 8.73 | 956304.0 |
| Oct 02, 2026 | 8.36 | 8.613 | 8.08 | 8.36 | 1.086M |
| Oct 01, 2026 | 9.95 | 9.99 | 8.28 | 8.33 | 1.952M |
| Sep 30, 2026 | 9.92 | 10.31 | 9.62 | 9.93 | 1.367M |
| Sep 29, 2026 | 9.66 | 10.06 | 9.43 | 9.89 | 1.501M |
| Sep 28, 2026 | 8.71 | 9.71 | 8.47 | 9.43 | 2.766M |
| Sep 25, 2026 | 8.57 | 8.68 | 8.40 | 8.54 | 672403.0 |
| Sep 24, 2026 | 8.32 | 8.60 | 8.20 | 8.50 | 636610.0 |
| Sep 23, 2026 | 8.70 | 8.70 | 8.39 | 8.40 | 610168.0 |
| Sep 22, 2026 | 8.26 | 8.82 | 8.16 | 8.70 | 994137.0 |
| Sep 21, 2026 | 7.80 | 8.60 | 7.60 | 8.33 | 1.300M |
| Sep 18, 2026 | 7.48 | 7.88 | 7.33 | 7.85 | 2.085M |
| Sep 17, 2026 | 7.31 | 7.40 | 7.085 | 7.22 | 765417.0 |
| Sep 16, 2026 | 7.25 | 7.33 | 7.055 | 7.21 | 687079.0 |
| Sep 15, 2026 | 7.05 | 7.19 | 6.81 | 7.16 | 779518.0 |
| Sep 14, 2026 | 7.03 | 7.18 | 6.82 | 7.13 | 752309.0 |
| Sep 11, 2026 | 6.93 | 7.02 | 6.70 | 6.94 | 790464.0 |
| Sep 10, 2026 | 6.76 | 7.04 | 6.66 | 6.89 | 893556.0 |
| Sep 09, 2026 | 7.595 | 7.605 | 6.782 | 6.86 | 1.446M |
| Sep 08, 2026 | 8.14 | 8.18 | 7.42 | 7.43 | 1.208M |
| Sep 04, 2026 | 8.14 | 8.38 | 7.99 | 8.24 | 986848.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 111.12 |
| Novavax, Inc. | 12.66 |
| AVITA Medical, Inc. | 13.37 |
| Iovance Biotherapeutics, Inc. | 14.56 |
| Amgen, Inc. | 417.57 |
Price Related Metrics
| PE Ratio | 2.799 |
| PS Ratio | 2.066 |
| Earnings Yield | 35.73% |
| Market Cap | 316.21M |
| Operating PE Ratio | 7.641 |
| Normalized PE Ratio | 7.433 |